Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 13.1 Billion
Market Forecast in 2033: USD 65.5 Billion
Market Growth Rate (2025-2033): 19.4%
United States genomics market size reached USD 13.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 65.5 Billion by 2033, exhibiting a growth rate (CAGR) of 19.4% during 2025-2033. Continuous improvements in medical infrastructure and diagnostic technologies, coupled with the inflating popularity of personalized medicines, are primarily driving the market growth.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/united-states-genomics-market/requestsample
United States Genomics Market Industry Trends and Drivers:
The United States genomics market is witnessing remarkable expansion, driven by rapid advancements in sequencing technologies, increasing investments in precision medicine, and growing applications in clinical diagnostics and pharmaceutical research. The rising prevalence of genetic disorders and chronic diseases is fueling the demand for genomic solutions, encouraging healthcare providers and research institutions to integrate cutting-edge genomic tools for early disease detection and personalized treatment strategies. Furthermore, the emergence of artificial intelligence (AI) and machine learning (ML) in genomics is revolutionizing data analysis and interpretation, accelerating the discovery of novel biomarkers and therapeutic targets. The expanding adoption of direct-to-consumer (DTC) genetic testing is also transforming the industry landscape, as individuals seek personalized insights into their health and ancestry, driving the demand for cost-effective and efficient sequencing technologies.
Key drivers of the United States genomics market include the increasing implementation of genomic data in drug development and the rising demand for precision oncology solutions. The growing emphasis on pharmacogenomics is enabling pharmaceutical companies to design targeted therapies that enhance treatment efficacy while minimizing adverse effects. Concurrently, government initiatives supporting genomic research, such as the Precision Medicine Initiative and the All of Us Research Program, are fostering innovation and accelerating the integration of genomics into mainstream healthcare. The expanding collaboration between biotechnology firms, academic institutions, and healthcare providers is further strengthening the market, facilitating groundbreaking advancements in gene editing technologies, including CRISPR-based genome engineering. Additionally, the rise of bioinformatics platforms and cloud computing solutions is streamlining genomic data storage, analysis, and sharing, enhancing research efficiency and scalability across the industry.
The increasing affordability and accessibility of next-generation sequencing (NGS) technologies are significantly enhancing the adoption of genomics across various sectors, including oncology, reproductive health, and rare disease diagnostics. The rising awareness among healthcare professionals and consumers about the benefits of genomic-based healthcare solutions is propelling market growth, encouraging continuous technological innovations in sequencing platforms and genomic data analysis tools. Moreover, the integration of multi-omics approaches, combining genomics with proteomics and metabolomics, is expanding the scope of precision medicine and driving new opportunities for drug discovery and development. With continuous advancements in sequencing methodologies, regulatory support for genetic testing, and growing private sector investments in genomic research, the United States genomics market is poised for sustained expansion, shaping the future of personalized healthcare and therapeutic innovations.
United States Genomics Market Industry Segmentation:
The report has segmented the market into the following categories:
Component Insights:
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
- Technology Insights:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
- Application Insights:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
- Others
End User Insights:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Breakup by Region:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=20477&flag=C
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
